20 articles
A year-long sham-controlled trial finds active VNS meaningfully improves daily function and quality of life in patients who failed 4+ antidepressants.
Researchers pinpoint a brainstem pathway linking vagal signals to pain suppression and mood, explaining how VNS therapy works.
New research reveals age-specific effects of vagus nerve stimulation on brain activity, with older adults showing stronger responses.
Small trial tests electrical brain stimulation to improve sleep quality and cognitive function in patients with vascular dementia.
Advanced neuroimaging shows how deep brain stimulation affects neural circuits, opening doors to more precise treatments.
Bilateral theta burst stimulation enhanced neural repair and restored function after stroke in non-human primates through multiple mechanisms.
AI-personalized neurostimulation tested in 67 UK teachers experiencing work-related rumination, with mixed but promising results.
Non-invasive brain stimulation techniques like TMS are helping stroke survivors recover language abilities by targeting specific brain regions.
New research reveals DBS doesn't just stimulate neurons — it physically remodels white matter and reshapes brain-wide connectivity.
A prospective trial finds 15 days of gamma-frequency tACS improves memory, attention, and executive function in mild Alzheimer's disease.
A landmark review from UCL argues DBS goes beyond temporary neuromodulation to drive lasting structural brain changes.
A take-home brain-computer interface restored daily communication and control for a man with motor neuron disease, marking a milestone in neurotechnology.
Revolutionary AI system discovers how consciousness works and identifies promising deep brain stimulation therapy for coma patients.
A multicenter RCT in JAMA Neurology finds electroacupuncture nearly doubles responder rates vs sham for chronic shingles nerve pain.
Neurosurgeon Dr. Casey Halpern explains how DBS and AI are reshaping treatment of OCD, addiction, and binge eating disorder.
Researchers at University of Padova argue lesion network mapping has overlooked biological constraints that may undermine its clinical applications.
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
Non-invasive sensory stimulation reduces brain plaques by up to 53% in studies, offering new hope for Alzheimer's treatment.
Dr. Nolan Williams breaks down how psilocybin, MDMA, ibogaine, and TMS are rewiring the brain to treat depression and PTSD.
